Payer

GLP-1 drugs like Ozempic and Wegovy are contributing to increasing premium rates in Michigan's small-group and individual insurance markets, the Detroit Free-Press reported July 10. 

BlueCross BlueShield of Tennessee reported $21.8 million in net income for 2022, down from $521.1 million in 2021. 

Leqembi, the newly-approved drug that can slow the progression of Alzhemier's disease, will cost Medicare billions each year, according to an analysis from KFF. 

A federal judge in Connecticut has denied a class-action bid against Cigna for allegedly overcharging members for medical equipment and violating its fiduciary duties under the Employee Retirement Income Security Act.

A New York judge has temporarily blocked New York City's plan to switch 250,000 retired city employees from traditional Medicare to an Aetna Medicare Advantage plan. 

Independence Blue Cross is partnering with financial services firm Sun Life to offer stop loss insurance to its self-funded group customers.

From its Optum arm striking a deal to acquire Amedisys, to a warning of rising medical costs, here are 11 updates from UnitedHealth Group that Becker's has reported since June 13: 

Nearly half of Medicare Advantage beneficiaries report having at least one health-related social need, a study published in the July issue of Health Affairs found. 

Five publicly traded companies have 50 percent of the Medicaid-managed care market, according to a July 6 analysis from KFF. 

Lawsuits from large companies and employers are increasingly being filed against third-party health plan administrators in an effort to access complete employee medical claims data.